MCK - McKesson Corporation
| Previous Close | 125.00 |
| Open | 124.29 |
| Bid | 0.00 x 1000 |
| Ask | 132.00 x 800 |
| Day's Range | 123.60 - 126.57 |
| 52 Week Range | 106.11 - 151.24 |
| Volume | 2,136,399 |
| Avg. Volume | 1,447,196 |
| Market Cap | 24.011B |
| Beta (3Y Monthly) | 1.54 |
| PE Ratio (TTM) | 730.64 |
| EPS (TTM) | 0.17 |
| Earnings Date | May 22, 2019 - May 28, 2019 |
| Forward Dividend & Yield | 1.56 (1.31%) |
| Ex-Dividend Date | 2019-05-31 |
| 1y Target Est | 140.77 |
- Investopedia•yesterday
The World's Top 10 Health Care Companies (UNH, MDT)
Discover the world's top 10 health care companies according to market capitalization, including a brief summary of each.
- Moody's•3 days ago
McKesson Corporation -- Moody's announces completion of a periodic review of ratings of McKesson Corporation
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of McKesson Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
- American City Business Journals•4 days ago
Exclusive: Why Charles Schwab says company's HQ could one day leave San Francisco
The founder and chairman of Charles Schwab said he's "not sure" whether the company's headquarters will remain in San Francisco.
- GuruFocus.com•6 days ago
McKesson Corp (MCK) Files 10-K for the Fiscal Year Ended on March 31, 2019
McKesson Corp provides medicines, pharmaceutical supplies, information and care management products and services across the healthcare industry. It operates with two segments namely McKesson Distribution Solutions and McKesson Technology Solutions. The dividend yield of McKesson Corp stocks is 1.20%.
- American City Business Journals•6 days ago
Comerica’s new CEO says California's cooling economy isn't dampening his enthusiasm for the state
The bank has almost every line of business in the Bay Area, including wealth management as well as lending to small and mid-sized companies and real estate investors.
- Thomson Reuters StreetEvents•7 days ago
Edited Transcript of MCK earnings conference call or presentation 8-May-19 12:00pm GMT
Q4 2019 McKesson Corp Earnings Call
- CNBC•11 days ago
Your first trade for Friday, May 10
The "Fast Money" traders share their first moves for the market open.
- Investopedia•12 days ago
Shares of McKesson Pop on Earnings
Shares responded positively to an earnings beat despite the political health care debate and pressures in international markets.
- Business Wire•12 days ago
CORRECTING and REPLACING McKesson Reports Fiscal 2019 Fourth-Quarter and Full-Year Results
IRVING, Texas-- -- Fourth-quarter fiscal 2019 revenues of $52.4 billion and full-year fiscal 2019 revenues of $214.3 billion, a full-year increase of 3%. Fourth-quarter GAAP loss per diluted share from continuing operations of $ and full-year GAAP earnings per diluted share from continuing operations of $0.17. Fourth-quarter Adjusted Earnings per diluted share of $3.69, up 6% from a year ago. Full-year ...
- Reuters•12 days ago
McKesson meets full-year profit estimates, renews partnership with CVS
The company also said it had renewed a distribution agreement with its largest client, CVS Health Inc, through 2023. "McKesson reported mixed end to its FY19, but in this environment that is likely to be enough especially as guidance met expectations," an Evercore ISI note said. The mid-point of the company's 2020 adjusted profit outlook of between $13.85 and $14.45 per share was a cent above the average analyst estimate, according to IBES data from Refinitiv.
Motley Fool•13 days agoMcKesson Corp (MCK) Q4 2019 Earnings Call Transcript
MCK earnings call for the period ending March 31, 2019.
Motley Fool•13 days agoMcKesson Gets Some Growth Back
The drug distributor isn’t back to full strength, but it has investors a bit more comfortable about its future.
- Zacks•13 days ago
McKesson (MCK) Q4 Earnings Beat, Revenues Miss Estimates
McKesson's (MCK) Q4 results benefit from higher revenues, gross margin expansion and solid show by U.S. Pharmaceutical and Specialty Solutions.
- Simply Wall St.•13 days ago
An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 46% Undervalued
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Today we will run through one way of estimating the intrinsic value of McKesson Corporation (NYSE:MCK...
- Zacks•13 days ago
McKesson (MCK) Tops Q4 Earnings Estimates
McKesson (MCK) delivered earnings and revenue surprises of 0.82% and -1.73%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- CNBC•13 days ago
Stocks making the biggest moves premarket: Office Depot, Lyft, Wendy's, TripAdvisor, Toyota & more
These are the stocks posting the largest moves before the bell.
- MarketWatch•13 days ago
McKesson stock up 1.3% after company posts earnings above Wall Street expectations
Shares of McKesson Corp. rose 1.3% in premarket trade Wednesday after the company reported fourth-quarter earnings that beat Wall Street expectations, though it missed on revenue. McKesson posted a loss of $796 million, or a loss of $4.17 per share, compared with a loss of $1.15 billion, or $5.58 per share, in the year-earlier quarter. Adjusted EPS came in at $3.69, above the FactSet consensus of $3.66. Revenue rose to $52.43 billion from $51.63 billion a year ago, but missed the FactSet consensus of $53.17 billion. The company said it expects full-year adjusted earnings per share of between $13.85 and $14.45. Shares of McKesson have gained 13.8% so far this year, while the S&P 500 has gained 15%.
- Associated Press•13 days ago
McKesson: Fiscal 4Q Earnings Snapshot
On a per-share basis, the San Francisco-based company said it had a loss of $4.17. Earnings, adjusted for non-recurring costs and restructuring costs, were $3.69 per share. The results beat Wall Street ...
- Reuters•13 days ago
Drug distributor McKesson posts smaller 4th-qtr loss
U.S. drug distributor McKesson Corp reported a smaller fourth-quarter loss on Wednesday, as its surgical distribution business was boosted by the company's recent acquisition of Medical Specialties Distributors ...
- TheStreet.com•13 days ago
McKesson Expected to Earn $3.66 a Share
is expected to report quarterly earnings of $3.66 a share on sales of $53.2 billion after the market closes on Wednesday, based on a FactSet survey of 14 analysts. McKesson is currently trading at a price-to-forward-earnings ratio of 8.7 based on the 12-month estimates of 17 analysts surveyed by FactSet. McKesson is one of the companies Real Money's Paul Price is watching closely.
- Markit•14 days ago
See what the IHS Markit Score report has to say about McKesson Corp.
McKesson Corp NYSE:MCKView full report here! Summary * Perception of the company's creditworthiness is negative * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for MCK with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MCK. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.88 billion over the last one-month into ETFs that hold MCK are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. MCK credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks•18 days ago
Can Core Business Unit Fuel McKesson (MCK) Q4 Earnings?
Anticipated growth across core business unit and solid show by Medical Surgical and European Pharmaceutical Solutions is likely to aid McKesson's (MCK) Q4 earnings. However, rising costs might be a dampener.
- Associated Press•18 days ago
West Virginia settles opioid lawsuit with McKesson for $37M
CHARLESTON, W.Va. (AP) — West Virginia has reached a $37 million settlement with the drug distributor McKesson in a lawsuit accusing the company of shipping millions of suspicious painkiller orders to the state as it was being ravaged by the opioid epidemic.
